Ashwagandha vs Holy Basil for PCOS: Which Adaptogen Is Actually Safer?
8 min read
A registered dietitian and clinician review is being arranged for this site. Until this article carries a named reviewer, treat it as a well-sourced summary of published guidance — not as a substitute for advice about your own case.
The short answer
Neither ashwagandha nor holy basil has a PCOS trial — holy basil’s whole human evidence base is one 60-day trial in 35 adults. The real difference is safety: ashwagandha carries liver injury and a pregnancy contraindication; holy basil has reduced fertility in animal studies and may slow blood clotting. Pick based on which risk applies to you.
Why Isn’t This a “Which Works Better for PCOS” Comparison?
Zero published trials have tested either ashwagandha or holy basil (tulsi, Ocimum sanctum) on menstrual cycles, ovulation, or androgen levels in women with PCOS, so there is no evidence base to rank one above the other on effectiveness. Both are marketed under the same “adaptogen” umbrella — a term with no regulatory or pharmacological definition, applied to unrelated plants on the promise that they help the body resist generalized stress. The full evidence gap behind ashwagandha’s PCOS marketing is covered in depth elsewhere on this site; this page exists to answer a narrower, more answerable question — given that neither has PCOS evidence, which one has the better-characterized safety profile for what it has actually been studied for, and who should avoid each one specifically.
What Has Each One Actually Been Tested For?
Ashwagandha’s human trial record is built on cortisol and stress-scale outcomes in stressed adults without PCOS, run for 8 to 12 weeks at 240–600 mg of standardized root extract daily. Holy basil’s human trial record is smaller and different in shape: a single controlled trial gave 35 adults with generalized anxiety disorder 500 mg of Ocimum sanctum leaf extract twice daily for 60 days and found a significant reduction in anxiety, stress, and depression scores (P < 0.001) alongside improved attention and adjustment. That is one small trial without a placebo arm described in the available report, in a psychiatric population rather than a PCOS one — thinner evidence than ashwagandha’s stress-trial base, not thicker.
| Herb | What was tested | Population | Dose & duration |
|---|---|---|---|
| Ashwagandha | Cortisol, DHEA-S, stress-scale scores | Stressed adults, not PCOS (multiple RCTs, pooled n=1,706) | 240–600 mg standardized extract, 8–12 weeks |
| Holy basil | Generalized anxiety, stress and depression scores | 35 adults with diagnosed GAD, not PCOS | 500 mg leaf extract twice daily, 60 days |
| Ashwagandha | Liver enzymes (as an adverse finding, not the study aim) | Case series, general adult population | Retail doses, 2 weeks–6 months before injury |
| Holy basil | Collagen-induced platelet aggregation (in vitro, human platelets) | Laboratory assay, not a clinical trial | 1–10 mg/mL extract concentration |
Neither table row answers the PCOS question. Both establish that the two herbs are studied for different things, in different ways, with different levels of scrutiny — which is the first reason “pick the more effective one” is the wrong frame here.
Does Holy Basil Reduce Fertility? What the Animal Studies Show
This is the finding most holy-basil-for-PCOS content leaves out, and it matters most on a site where many readers are trying to conceive. A 2019 study gave female rats 500 mg/kg body weight of Ocimum sanctum leaf extract daily for 15 days and found it raised serum progesterone and concluded, alongside a comparison compound, that the resulting hormonal shift reduced ovulation frequency and impaired fertility. A separate, earlier study in male rats found the same directional signal from the other side: a benzene extract of Ocimum sanctum leaves reduced sperm count and motility, an effect the authors found was reversible after stopping the extract.
Does Holy Basil Thin the Blood?
A 2026 laboratory study found an ethanolic extract of Ocimum sanctum leaves significantly and dose-dependently inhibited collagen-induced platelet aggregation in human blood samples, blocking several of the signaling steps platelets use to clump together. This is an in vitro finding, not a clinical bleeding-risk trial — nobody has measured whether people taking holy basil supplements actually bruise more easily or bleed longer after a cut or a procedure. But the mechanism is real and specific enough that it changes who should be cautious: anyone on a blood thinner (warfarin, aspirin, clopidogrel) or scheduled for surgery or a dental procedure has a concrete reason to flag holy basil to their prescriber before starting it, the same way they would flag any other supplement with a plausible antiplatelet effect.
Side-by-Side: Who Should Avoid Which
| Risk category | Ashwagandha | Holy basil |
|---|---|---|
| Liver | Documented liver injury in case series; dedicated NIH LiverTox entry | No documented human liver injury cases identified |
| Thyroid | Raises T3/T4 in a randomized trial of subclinical hypothyroidism; interacts with levothyroxine | No thyroid-hormone trial identified either way |
| Pregnancy / TTC | No human pregnancy safety data; traditional abortifacient use debated but unresolved | Reduced fertility in animal studies in both sexes; reversible after stopping in the male-rat study |
| Bleeding | No antiplatelet signal identified | Inhibits platelet aggregation in a human-platelet laboratory assay |
| Autoimmune / immunosuppressants | Documented immune-modulating activity; caution advised | Not specifically assessed in this evidence set |
Read the table by your own situation rather than by a total score. If you have Hashimoto’s, take levothyroxine, or have any liver condition, ashwagandha carries the more specific documented risk. If you are pregnant, breastfeeding, actively trying to conceive, or take a blood thinner or have a procedure scheduled, holy basil carries the more specific documented risk. Neither profile is “the safer herb” in general — each is safer for a different reader.
Who This Comparison Cannot Help
If your goal is a measured effect on your cycle, your androgen levels, or your insulin resistance, neither herb has a PCOS trial to point to — this page cannot recommend one over the other for an outcome nobody has tested for either substance. If you are choosing purely on cost or taste, that is a preference this article has no evidence-based basis to weigh in on. And if you already take levothyroxine, have liver disease, are trying to conceive, or take a blood thinner, this comparison has already made the decision for you in the tables above — the question isn’t which is more effective, it’s which risk you’re not carrying.
You may see PCOS written as polyendocrine metabolic ovarian syndrome (PMOS), after a 2026 global consensus of more than 50 organisations renamed it. Nothing about the evidence gaps above changes with the name — this article uses PCOS because that is still what most readers search.
Common questions
Is ashwagandha or holy basil better for PCOS?
Neither has a PCOS trial on cycles, androgens, or insulin, so there is no evidence to say one works better. The real difference is safety: ashwagandha has documented liver and thyroid interactions; holy basil has animal antifertility and antiplatelet signals.Can holy basil affect fertility?
In animal studies, yes. A 2019 rat study found holy basil leaf extract raised progesterone and reduced ovulation frequency; a 2002 study found a reversible drop in sperm count and motility in male rats. No human fertility trial has tested it either way.Does holy basil thin the blood?
A 2026 laboratory study found holy basil leaf extract significantly inhibited platelet aggregation in human blood samples. This is an in vitro finding, not a clinical bleeding trial, but it's a reason to flag holy basil before surgery or if you take a blood thinner.Is ashwagandha safer than holy basil?
Not in general — each carries a different, more specific risk. Ashwagandha has documented liver injury cases and a thyroid-hormone interaction. Holy basil has animal antifertility findings and an antiplatelet signal. Which is 'safer' depends on which risk applies to you.Can I take ashwagandha and holy basil together?
No trial has tested the combination in anyone, PCOS or otherwise. Combining two under-tested herbs adds their separate risk profiles together rather than cancelling them out, so treat that as a reason for more caution, not less.
Your Next Step
If cortisol and chronic stress are what brought you to either of these, the cortisol and stress mechanism in PCOS covers that connection directly, without a supplement attached. If you are already taking one of these alongside something else, the supplement interaction checker is a faster way to spot a conflict than reading every label by hand. For the deep-dive evidence and risk profile behind each herb individually, see the full ashwagandha evidence and risk review and the full maca evidence review, which covers the other supplement most often marketed alongside these two as a “hormone balancer.”
- PCOS Supplement Routine: Morning vs Night, Per the TrialsNo PCOS trial tested a full morning-vs-night supplement routine. What each supplement's own trials actually specified, assembled into one realistic daily plan.
- Alpha-Lipoic Acid vs Berberine for PCOS: Different Jobs, Different EvidenceAlpha-lipoic acid and berberine are sold as interchangeable PCOS insulin sensitisers. Their mechanisms, evidence, and safety profiles are not the same.
- Ashwagandha for PCOS: The Real Evidence and the Real RisksNo PCOS trial has tested ashwagandha on cycles, androgens or insulin — only cortisol trials in people without it. The liver, thyroid and pregnancy risks.
- Ashwagandha vs Maca for PCOS: They Are Not the Same ChoiceMarketed as interchangeable hormone balancers, they aren't. Neither has PCOS trial evidence — the real decision is which one's risks you can rule out first.
Sources
- 1.Bhattacharyya D, Sur TK, Jana U, Debnath PK. Controlled programmed trial of Ocimum sanctum leaf on generalized anxiety disorders. Nepal Med Coll J. 2008.
- 2.Poli V, Challa C. A comparative study of eugenol and Ocimum sanctum Linn. leaf extract on the antifertility effect in female albino rats. J Chin Med Assoc. 2019.
- 3.Ahmed M, Ahamed RN, Aladakatti RH, Ghosesawar MG. Reversible anti-fertility effect of benzene extract of Ocimum sanctum leaves on sperm parameters and fructose content in rats. J Basic Clin Physiol Pharmacol. 2002.
- 4.Maaz M, Balupillai A, Periyakali S, et al. Protective Effects of the Ethanolic Leaf Extract of Ocimum sanctum L. on Collagen-Induced Human Platelet Aggregation and CCl4-Induced Hepatotoxicity in Rats. Molecules. 2026.
- 5.National Institute of Diabetes and Digestive and Kidney Diseases. Ashwagandha. In: LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. 2012.
- 6.Sharma AK, Basu I, Singh S. Efficacy and Safety of Ashwagandha Root Extract in Subclinical Hypothyroid Patients: A Double-Blind, Randomized Placebo-Controlled Trial. J Altern Complement Med. 2018.
- 7.Tallon MJ, Koturbash I, Blum JL. A Systematic and Ethnobotanical Review of Ashwagandha's (Withania somnifera) Teratogenic and Abortifacient Potentials. Phytother Res. 2026.
- 8.Teede HJ, Khomami MB, Morman R, et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. Lancet. 2026.